PVI
MRNA icon

Pura Vida Investments’s Moderna MRNA Stock Holding History

Pura Vida Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,000
Closed -$8.61M – 250
2022
Q1 		$8.61M Buy
+50,000
New +$8.42M 0.28% 89
2020
Q4 		– Sell
-100,000
Closed -$7.08M – 212
2020
Q3 		$7.08M Buy
+100,000
New +$6.97M 0.36% 54

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's MRNA Position: Q2 2021 in Review

Pura Vida Investments sold out of Moderna (MRNA) in Q2 2021, closing a stake of 26,791 shares — an estimated $3.51M sold.

Pura Vida Investments first reported a position in MRNA in Q1 2021 and held it in 1 quarter. The position peaked at $3.51M in Q1 2021. 904 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • Pura Vida Investments reported no remaining Moderna position as of Q2 2021 after selling out during the quarter.
  • Pura Vida Investments sold 26,791 Moderna shares in Q2 2021, an estimated $3.51M.
  • Pura Vida Investments first reported a position in Moderna in Q1 2021 and held it in 1 quarter.
  • Pura Vida Investments's Moderna position peaked at $3.51M in Q1 2021.
  • 904 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.